Market Overview:
The global biochip products and services market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biochips for gene sequencing and gene expression, clinical diagnosis and treatment (cancer diagnosis), genomics and toxicogenomics, proteomics, drug discovery, and other applications. Additionally, the growing demand for personalized medicine is also contributing to the growth of this market. On the basis of type, the global biochip products and services market can be segmented into biochips and services. The biochip segment is further sub-segmented into microarray chips, DNA chips/probes arrays chip), protein chips (2D gel electrophoresis chip)and lab-on-a-chip devices). The service segment includes assay development services,, contract research organization (CRO)services,, manufacturing support services,, marketing & sales support servies,.and others). On the basis of application,.
Product Definition:
A biochip is a device that contains microscopic arrays of biomolecules, such as DNA, proteins, or antibodies. Biochips are used for many purposes, including identification (e.g., paternity testing), diagnosis (e.g., detection of diseases), and drug discovery.
Biochip:
Biochip is a device used for the detection and analysis of biological molecules such as DNA, RNA, hormones, enzymes and proteins. Biochips are integrated with bio-magnetic particles or nanoparticles which help in separation of these molecules based on their size & properties. The major factor driving the growth factor in this market is increasing demand for rapid diagnostic tests due to growing prevalence of chronic diseases such as cancer & diabetes.
Services:
Bioinformatics Services Market Size, Share & Trends Analysis Report By Application (Drug Discovery, Diagnostics), By End Use (Academic Research Institutes, Contract Research Organizations), And Segment Forecasts to 2020 -> The global bioinformatics services market size was valued at USD 1.5 billion in 2013 and is expected to grow at a CAGR of XX% from 2014 to 2020.
Application Insights:
The clinical diagnosis and treatment segment dominated the global biochip products and services market in 2017. This is owing to an increase in demand for point-of-care diagnostics that are highly accurate, sensitive, specific, rapid and easy to use. Moreover, an increase in the adoption of biochips for drug discovery is expected to drive growth over the forecast period.
Global biochip products.
Proteomics offers various advantages such as increased sensitivity & specificity compared to genomics or genomic technologies alone; reduced costs; greater ease of operation; faster turnaround time; improved data quality due to higher accuracy & precision of techniques used during analysis like mass spectroscopy or gel extraction procedures.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased funding for genomic research and technological advancements, and high adoption of advanced biochips across laboratories. Moreover, increasing government initiatives to support genomic studies are also expected to drive regional growth over the forecast period. For instance, National Institutes of Health (NIH) launched a new initiative named “U54 Center for Sequencing & Genomics†in August 2018 with an aim towards accelerating genome sequencing projects using Illumina’s next-generation sequencing platforms at U.S.
Growth Factors:
- Increasing demand for biochip products and services in the life science research market.
- Growing demand for personalized medicine and companion diagnostics.
- Advances in biochip technology and increasing use of microfluidics platforms.
- Rising number of biotechnology and pharmaceutical companies investing in R&D to develop new biochip products and services.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biochip Products and Services Market Research Report
By Type
Biochip, Services
By Application
Gene Sequencing and Gene Expression, Clinical Diagnosis and Treatment (Cancer Diagnosis), Genomics and Toxicogenomics, Proteomics, Drug Discovery, Other
By Companies
Fluidigm, Affymetrix, Illumina, Luminex, Bio-Rad Laboratories, Perkin Elmer, Life Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Biochip Products and Services Market Report Segments:
The global Biochip Products and Services market is segmented on the basis of:
Types
Biochip, Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gene Sequencing and Gene Expression, Clinical Diagnosis and Treatment (Cancer Diagnosis), Genomics and Toxicogenomics, Proteomics, Drug Discovery, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fluidigm
- Affymetrix
- Illumina
- Luminex
- Bio-Rad Laboratories
- Perkin Elmer
- Life Technologies
Highlights of The Biochip Products and Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biochip
- Services
- By Application:
- Gene Sequencing and Gene Expression
- Clinical Diagnosis and Treatment (Cancer Diagnosis)
- Genomics and Toxicogenomics
- Proteomics
- Drug Discovery
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biochip Products and Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biochip products and services are those that use chips to store, process, or transmit data.
Some of the key players operating in the biochip products and services market are Fluidigm, Affymetrix, Illumina, Luminex, Bio-Rad Laboratories, Perkin Elmer, Life Technologies.
The biochip products and services market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biochip Products and Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biochip Products and Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biochip Products and Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biochip Products and Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biochip Products and Services Market Size & Forecast, 2020-2028
4.5.1 Biochip Products and Services Market Size and Y-o-Y Growth
4.5.2 Biochip Products and Services Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Biochip
5.2.2 Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Gene Sequencing and Gene Expression
6.2.2 Clinical Diagnosis and Treatment (Cancer Diagnosis)
6.2.3 Genomics and Toxicogenomics
6.2.4 Proteomics
6.2.5 Drug Discovery
6.2.6 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biochip Products and Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biochip Products and Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Biochip
9.6.2 Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Gene Sequencing and Gene Expression
9.10.2 Clinical Diagnosis and Treatment (Cancer Diagnosis)
9.10.3 Genomics and Toxicogenomics
9.10.4 Proteomics
9.10.5 Drug Discovery
9.10.6 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Biochip
10.6.2 Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Gene Sequencing and Gene Expression
10.10.2 Clinical Diagnosis and Treatment (Cancer Diagnosis)
10.10.3 Genomics and Toxicogenomics
10.10.4 Proteomics
10.10.5 Drug Discovery
10.10.6 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Biochip
11.6.2 Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Gene Sequencing and Gene Expression
11.10.2 Clinical Diagnosis and Treatment (Cancer Diagnosis)
11.10.3 Genomics and Toxicogenomics
11.10.4 Proteomics
11.10.5 Drug Discovery
11.10.6 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Biochip
12.6.2 Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Gene Sequencing and Gene Expression
12.10.2 Clinical Diagnosis and Treatment (Cancer Diagnosis)
12.10.3 Genomics and Toxicogenomics
12.10.4 Proteomics
12.10.5 Drug Discovery
12.10.6 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Biochip
13.6.2 Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Gene Sequencing and Gene Expression
13.10.2 Clinical Diagnosis and Treatment (Cancer Diagnosis)
13.10.3 Genomics and Toxicogenomics
13.10.4 Proteomics
13.10.5 Drug Discovery
13.10.6 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biochip Products and Services Market: Competitive Dashboard
14.2 Global Biochip Products and Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fluidigm
14.3.2 Affymetrix
14.3.3 Illumina
14.3.4 Luminex
14.3.5 Bio-Rad Laboratories
14.3.6 Perkin Elmer
14.3.7 Life Technologies
